Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Should Investors Be Worried About Moderna's Leadership Change?

TheMotleyFool

0 0

Should Investors Be Worried About Moderna's Leadership Change?

Moderna (NASDAQ: MRNA) recently announced that Tal Zaks, the biotech's chief medical officer, is planning on leaving the company in late September. In this video from Motley Fool Live, recorded on March 1, Fool.com Contributors Brian Orelli and Keith Speights discuss Zaks' history with Moderna and the impact his departure may have on the company's future.

Source Fool.com

Like: 0

MRNA

Share